1. Sillence, D.O.; Senn, A.; Danks, D.M. Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 1979, 16 (2), 101-116.

2. Glorieux, F.H.; Rauch, F.; Plotkin, H.; Ward, L.; Travers,

R.; Roughley, P.; Lalic, L.; Glorieux, D.F.; Fassier, F.; 14. Bishop, N.J. Type V osteogenesis imperfecta: A new form of brittle bone disease. J. Bone Miner. Res. 2000, 15 (9), 1650-1658.

3. Glorieux, F.H.; Ward, L.M.; Rauch, F.; Lalic, L.; 15. Roughley, P.J.; Travers, R. Osteogenesis imperfecta type

VI: A form of brittle bone disease with a mineralization defect. J. Bone Miner. Res. 2002, 17 (1), 30-38. 16.

4. Ward, L.M.; Rauch, F.; Travers, R.; Chabot, G.; Azouz, E.M.; Lalic, L.; Roughley, P.J.; Glorieux, F.H. Osteo-genesis imperfecta type VII: An autosomal recessive form of brittle bone disease. Bone 2002, 31 (1), 12-18.

5. Labuda, M.; Morissette, J.; Ward, L.M.; Rauch, F.; Lalic,

L.; Roughley, P.J.; Glorieux, F.H. Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone 2002, 31 (1), 19 -25.

Byers, P.H.; Steiner, R.D. Osteogenesis imperfecta. Annu. Rev. Med. 1992, 43, 269-282.

Marini, J.C.; Lewis, M.B.; Wang, Q.; Chen, K.J.; Orrison, B.M. Serine for glycine substitution in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. J. Biol. Chem. 1993, 268 (4), 2667 -2673. Zhuang, J.; Tromp, G.; Kuivaniemi, H.; Castells, S.; Bugge, M.; Prockop, D.J. Direct sequencing of PCR products derived from cDNAs for the pro alpha 1 and proa alpha 2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta. Hum. Mutat. 1996, 7 (2), 89-99. Nuytinck, L.; Sayli, B.S.; Karen, W.; De Paepe, A. Prenatal diagnosis of osteogenesis imperfecta type I by COL1A1 null-allele testing. Prenat. Diagn. 1999, 19 (9), 873-875.

Grange, D.K.; Lewis, M.B.; Marini, J.C. Analysis of cultured chorionic villi in a case of osteogenesis imperfecta type II: Implications for prenatal diagnosis. Am. J. Med. Genet. 1990, 36 (2), 258 -264.

Cole, W.G. Early surgical management of severe forms of osteogenesis imperfecta. Am. J. Med. Genet. 1993, 45 (2), 270-274.

Glorieux, F.H. Bisphosphonate therapy for severe osteo-genesis imperfecta. J. Pediatr. Endocrinol. Metab. 2000, 13 (Suppl. 2), 989-992.

Horwitz, E.M.; Prockop, D.J.; Fitzpatrick, L.A.; Koo, W.W.; Gordon, P.L.; Neel, M.; Sussman, M.; Orchard, P.; Marx, J.C.; Pyeritz, R.E.; Brenner, M.K. Transplantability and therapeutic effects of bone marrow-derived mesen-chymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5 (3), 309-313.

Dawson, P.A.; Marini, J.C. Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. Nucleic Acids Res. 2000, 28 (20), 4013-4020.

Niyibizi, C.; Smith, P.; Mi, Z.; Robbins, P.; Evans, C. Potential of gene therapy for treating osteogenesis imperfecta. Clin. Orthop. 2000, 379, S126-133. Supplement. Forlino, A.; Porter, F.D.; Lee, E.J.; Westphal, H.; Marini, J.C. Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in Brt1IV mice. J. Biol. Chem. 1999, 274 (53), 37923-37931.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook

Post a comment